Bristol Laboratories

Bristol Laboratories, established in 1997, is a dynamic British pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of generic medicines. Operating within the Pharmaceuticals and Healthcare sectors, the company has built a significant presence across the UK and Europe. With a revenue of $39.4M and an employee range of 500-1,000 individuals, Bristol Laboratories demonstrates substantial operational scale and market impact. Its product portfolio includes a range of generic pharmaceuticals, focusing on therapeutic areas such as cardiovascular disease, alongside consumer healthcare products. The company's commitment to quality and accessibility in medicine is a core tenet of its business model.

The organization employs a dedicated team focused on innovation and efficient production processes. With 3 locations, Bristol Laboratories manages a complex supply chain to ensure timely delivery of its pharmaceutical products. The company's strategic growth is supported by its experienced workforce, and for further insight into its personnel, one can Meet Bristol Laboratories's team. This focus on human capital is integral to its mission of providing affordable and effective generic medications to a broad patient base across its operational territories.

Bristol Laboratories competes in a robust market alongside entities like Animalcare Group, INNEO Solutions, and Wockhardt UK, among others. Its strategic positioning in the European market is further solidified by its adherence to stringent regulatory standards and its continuous efforts to expand its therapeutic offerings. The company's B2B focus underscores its role as a key supplier within the pharmaceutical distribution network, contributing to healthcare accessibility and affordability.